Virological, immunological and histological aspects in adult β-thalassemic patients with chronic hepatitis C virus infection

Liver International

Volumn 24, Issue 3, 2004, Pages 204-209

  Siagris, Dimitrios ^a,b   Giannakoulas, N ^a   Christofidou, M ^a   Tsamandas, A ^a   Lekkou, A ^a   Thomopoulos, K ^a   Zoumbos, N ^a   Labropoulou Karatza, Ch ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b NONE   (Greece)

Author keywords

Autoantibodies; Cryoglobulins; Hepatitis C virus; Histopathology; Viral load; thalassemia major

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CRYOGLOBULIN; DEFERIPRONE; DEFEROXAMINE; GAMMA INTERFERON; VIRUS RNA;

ADULT; ARTICLE; AUTOIMMUNITY; BETA THALASSEMIA; BLOOD DONOR; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOMODULATION; IRON OVERLOAD; LIVER BIOPSY; LIVER HISTOLOGY; MALE; PREVALENCE; SCORING SYSTEM; STAGING; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 3142743977     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2004.0919.x     Document Type: Article

References (33)

1. Schwimmer J B, Balistreri W F. Transmission, natural history, and treatment of hepatitis C virus infection in the pediatric population. Semin Liver Dis 2000; 20: 37-46.
2. Vrielink H, van Der Poel C L, Reesink H W, Zaaijer H L, Lelie P N. Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Case report. Vox Sang 1995; 68: 55.
3. Allander T, Gruber A, Naghavi M, et al. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995; 345: 603.
4. Pawlotsky J M, Ben Yahia M, Andre C, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case control study. Hepatology 1994; 19: 841-8.
5. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
6. Giardina P J, Grady R W, Ehlers K H, et al. Pathophysiology of iron overload. Ann NY Acad Sci 1998; 850: 191-201.
7. Dwyer J, Wood C, McNamara J, et al. Abnormalities in the immune system of children with beta thalassemia major. Clin Exp Immunol 1987; 68: 621-9.
8. Ezer U, Gulderen F, Culha V K, Akgul N, Gurbuz O. Immunological status of thalassemia syndrome. Pediatr Hematol Oncol 2002; 19: 51-8.
9. Farmakis D, Giakoumis A, Polymeropoulos E, Aessopos A. Pathogenetic aspects of immune deficiency associated with β thalassemia. Med Sci Monit 2003; 9(1): 19-22.
10. Giardina P J, Grady R W. Chelation therapy in beta-thalassemia - the benefits and limitations of desferrioxamine. Semin Hematol 1995; 32: 304-12.
11. Cunningham-Rundles S, Giardina P J, Grady R W, Califano C, McKenzie P, de Sousa M. Effect of transfusional iron overload on immune response. J Infect Dis 2000; 182: 115-21.
12. Gretch D, Corey L, Wilson J, et al. Assesment of hepatitis virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia corellates with advanced stage of disease. J Infect Dis 1994; 169: 1219-25.
13. Eyster M E, Fried M W, Di Bisceglie A M, Goedert J J. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immuno-deficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. Blood 1994; 84: 1020-3.
14. Chazouilleres O, Kim M, Combs C, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994; 106: 994-9.
15. Grady R W, Akbar A N, Giardina P J, Hilgartner M W, de Sousa M. Disproportionate lymphoid cell subsets in thalassemia major: the relative contributions of transfusion and splenectomy. Br J Haematol 1985; 59: 713-24.
16. Rehermann B. Interaction between the hepatitis C virus and the immune system. Semin Liver Dis 2000; 20: 127-41.
17. Farci P, Purcell R H. Clinical significance of hepatitis C virus genotypes and quasispecies. Semin Liver Dis 2000; 20: 103-26.
18. Agnello V, Chung R T, Kaplan L M. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-5.
19. Dammacco F, Sansonno D, Piccoli C, Racanelli V, Paola D' Amore, Lauletta G. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia and overt B-cell malignancy. Semin Liver Dis 2000; 20: 143-57.
20. Dessi C, Clemente M G, Diana G, et al. Cryoglobulinemia in transfused-dependent thalassemia major. Clin Exp Rheumatol 1995; 13(Suppl. 13): 149-51.
21. Perniola R, de Rinaldis C, Accogli E, Lobreglio G. Prevalence and clinical features of cryoglobulinemia in multitransfused β-thalassaemia patients. Ann Rheum Dis 1999; 58: 698-702.
22. Clifford B D, Donahue D, Smith L, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995; 21: 613-9.
23. Sinniah D, Yadav M. Elevated IgG and decreased complement component C3 and factor B in B-thalassemia major. Acta Paediatr Scand 1981; 70: 547-50.
24. Quintiliani L, Mastromonaco A, Giuliani E, et al. Immune profile alterations in thalassaemic patients. Boll Ist Sieroter Milan 1983; 62(6): 524-30.
25. Walker E A, Walker S M. Effects of iron overload on the immune system. Ann Clin Lab Sci 2000; 30: 354-65.
26. Johnson P J, Mcfarlane I G. Meeting report. International autoimmune hepatitis group. Hepatology 1993; 18: 998-1005.
27. Poynard T, Ratziu V, Benmanov Y, Di Martino V, Bedossa P, Opolon P. Fibrosis in patients with chronic hepatitis C: detection and significance. Semin Liver Dis 2000; 20: 47-55.
28. Angelucci E, Muretto P, Lucarelli G, et al. Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Blood 1997; 90: 994-8.
29. Angellucci E, Muretto P, Nicolucci A, et al. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood 2002; 100: 17-21.
30. Lau J Y, Davis G L, Kniffen J, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501-4.
31. Alberti A, Chemello L, Benvegnu L. Natural history of hepatitis C. Review. J Hepatol 1999; 31: 17-24.
32. Vogt M, Lang T, Frosner G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999; 341: 866-70.
33. Freeman A J, Dore G J, Law M G, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001; 34: 809-16.